Morgan Lawson, LCSW-C in Hagerstown, MD - Social Worker

Morgan Lawson, LCSW-C is a Social Worker - Clinical based in Hagerstown, Maryland. Morgan Lawson is licensed to practice in Maryland (license number 18252) and her current practice location is 201 N Burhans Blvd, Hagerstown, Maryland. She can be reached at her office (for appointments etc.) via phone at (301) 791-2660.

NPI number for Morgan Lawson is 1205205242 and her current mailing address is 201 N Burhans Blvd, Hagerstown, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1205205242.

Contact Information

	Morgan Lawson, LCSW-C
	201 N Burhans Blvd, Hagerstown, MD 21740-4677
	(301) 791-2660
	Not Available

Healthcare Provider's Profile

Full Name	Morgan Lawson
Gender	Female
Speciality	Social Worker - Clinical
Location	201 N Burhans Blvd, Hagerstown, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1205205242
Provider Enumeration Date: 09/21/2015
Last Update Date: 04/21/2016

Medical Identifiers

Medical identifiers for Morgan Lawson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1205205242	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	18252 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Morgan Lawson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Morgan Lawson, LCSW-C 201 N Burhans Blvd, Hagerstown, MD 21740-4677 Ph: () -	Morgan Lawson, LCSW-C 201 N Burhans Blvd, Hagerstown, MD 21740-4677 Ph: (301) 791-2660

News Archive

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

New insights into addiction

A new comprehensive review by researchers at the Montreal Neurological Institute (MNI), McGill University and the University of Cambridge, England provides vital insights into the neurological basis of addiction by investigating Parkinson's disease patients, who in some instances develop various addictions when undergoing medical treatment.

Large study examines diagnostic yield of colonoscopy to investigate melena

A new study from researchers in Oregon reports that the diagnostic yield of colonoscopy to investigate melena after a nondiagnostic upper endoscopy is lower, 4.8 percent, than previously reported. The rate of therapeutic intervention in this population is very low; therefore, patients with melena and a nondiagnostic upper endoscopy who are stable and without evidence of ongoing bleeding may be able to safely undergo elective colonoscopy.

EMA recommends orphan medicinal product designation for XOMA 052 in treatment of Behcet's disease

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medicines Agency (EMA) has adopted a positive opinion and recommends the granting of orphan medicinal product designation for XOMA 052, an antibody to interleukin-1 beta, for the treatment of Behcet's disease. Positive opinions are submitted to the European Commission for decision and are generally adopted within 30 days of receipt.

Study looks at transpalatal advancement pharyngoplasty procedure for sleep apnea

Treatment with surgery or an oral appliance that adjusts the jaw is associated with improvements in obstructive sleep apnea, a condition caused by blocked upper airways in which patients periodically stop breathing during sleep, according to two reports in the May issue of Archives of Otolaryngology–Head & Neck Surgery.

Social Worker in Hagerstown, MD

Annette Jeffers, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 370 Virginia Ave, Hagerstown, MD 21740 Phone: 301-733-3130
Victoria Leizer, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5 Public Sq # 428, Hagerstown, MD 21740 Phone: 301-514-3960
Vicki S Churchey, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 18714 N Village, Hagerstown, MD 21742 Phone: 301-733-0330 Fax: 301-733-4038
Ms. Patti Kay Cooper, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11116 Medical Campus Rd, Suite 2989, Hagerstown, MD 21742 Phone: 301-766-7600 Fax: 301-766-7702
Tammy Sherrard, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1180 Professional Ct, Hagerstown, MD 21740 Phone: 301-791-3045 Fax: 240-313-3071
Mr. Edward John Soffe, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 113 S Prospect St, Hagerstown, MD 21740 Phone: 301-573-2800
Desirae Mehaffie, LCSWC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1180 Professional Ct, Hagerstown, MD 21740 Phone: 301-791-3045 Fax: 240-313-3071

Morgan Lawson, LCSW-C - Clinical Social Worker in Hagerstown, MD